News Coverage 08.25.20 Share on Twitter Share on Facebook Share on LinkedIn The Parker Institute for Cancer Immunotherapy Appoints John Connolly, PhD, as Chief Scientific Officer Related Announcement, Our Impact PICI at AACR 2025: Data, Direction, Impact Announcement, Press Release Dr. Ira Mellman Joins PICI as President of Research Announcement, Press Release Dr. Karen E. Knudsen Appointed CEO of PICI